Posts With Tag Immunopharma

Showing 1 - 2 of 2 Posts

Estrella Immunopharma 8-K Report: Insights on Stock & Warrants (Feb 19, 2025)

$ESLA

•

Form 8-K

•

2025-02-20

Last updated: 3 months ago

Estrella Immunopharma 8-K Report: Insights on Stock & Warrants (Feb 19, 2025)

Explore Estrella Immunopharma, Inc.'s latest 8-K filing detailing stock and warrants, key financial metrics, and corporate updates vital for investors.

Biotechnology Immunopharma NASDAQ ESLA Warrants Financial Reporting

$LYEL

•

Form 8-K/A

•

2025-01-10

Last updated: 4 months ago

Lyell Immunopharma 8-K/A Report: Key Updates for Investors (LYEL)

Lyell Immunopharma, Inc. filed an 8-K/A on October 31, 2024, revealing significant updates. Discover crucial insights about their financials and corporate developments.

Lyell Immunopharma biotechnology NASDAQ LYEL financial reporting 8-K filing